320 related articles for article (PubMed ID: 35011320)
1. Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation.
Giampà M; Amundarain MJ; Herrera MG; Tonali N; Dodero VI
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011320
[TBL] [Abstract][Full Text] [Related]
2. Manganese promotes α-synuclein amyloid aggregation through the induction of protein phase transition.
Xu B; Huang S; Liu Y; Wan C; Gu Y; Wang D; Yu H
J Biol Chem; 2022 Jan; 298(1):101469. PubMed ID: 34871547
[TBL] [Abstract][Full Text] [Related]
3. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
4. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Teng Y; Zhao J; Ding L; Ding Y; Zhou P
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
[TBL] [Abstract][Full Text] [Related]
5. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
[TBL] [Abstract][Full Text] [Related]
6. Aggregation and phase separation of α-synuclein in Parkinson's disease.
Han W; Wei M; Xu F; Niu Z
Chem Commun (Camb); 2024 Jun; 60(52):6581-6590. PubMed ID: 38808534
[TBL] [Abstract][Full Text] [Related]
7. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
Peng C; Gathagan RJ; Lee VM
Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
[TBL] [Abstract][Full Text] [Related]
8. The disordered protein SERF promotes α-Synuclein aggregation through liquid-liquid phase separation.
Liu HN; Wang T; Hu JJ; Chen L; Shi X; Li YM; Luo SZ
J Biol Chem; 2024 Mar; 300(3):105667. PubMed ID: 38272228
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
10. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition.
Xu B; Mo X; Chen J; Yu H; Liu Y
Chembiochem; 2022 Aug; 23(16):e202200216. PubMed ID: 35657723
[TBL] [Abstract][Full Text] [Related]
11. Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation.
Huang S; Xu B; Liu Y
Biochem Biophys Res Commun; 2022 May; 603():13-20. PubMed ID: 35276458
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
13. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
Singh P; Bhat R
ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
[TBL] [Abstract][Full Text] [Related]
14. Phase separation and other forms of α-Synuclein self-assemblies.
Poudyal M; Sakunthala A; Mukherjee S; Gadhe L; Maji SK
Essays Biochem; 2022 Dec; 66(7):987-1000. PubMed ID: 36373662
[TBL] [Abstract][Full Text] [Related]
15. An Innate Host Defense Protein β
Rani K; Pal A; Gurnani B; Agarwala P; Sasmal DK; Jain N
J Mol Biol; 2023 Nov; 435(22):168285. PubMed ID: 37741548
[TBL] [Abstract][Full Text] [Related]
16. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
17. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
Palazzi L; Leri M; Cesaro S; Stefani M; Bucciantini M; Polverino de Laureto P
Biochem Pharmacol; 2020 Mar; 173():113722. PubMed ID: 31756328
[TBL] [Abstract][Full Text] [Related]
18. Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.
Haque R; Maity D
Bioorg Med Chem Lett; 2023 Apr; 86():129257. PubMed ID: 36966976
[TBL] [Abstract][Full Text] [Related]
19. DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization.
Popova B; Wang D; Pätz C; Akkermann D; Lázaro DF; Galka D; Kolog Gulko M; Bohnsack MT; Möbius W; Bohnsack KE; Outeiro TF; Braus GH
PLoS Genet; 2021 Mar; 17(3):e1009407. PubMed ID: 33657088
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
